Common name
cyclohexylmethanol
IUPAC name
cyclohexylmethanol
SMILES
C1(CCCCC1)CO
Common name
cyclohexylmethanol
IUPAC name
cyclohexylmethanol
SMILES
C1(CCCCC1)CO
INCHI
InChI=1S/C7H14O/c8-6-7-4-2-1-3-5-7/h7-8H,1-6H2
FORMULA
C7H14O
Common name
cyclohexylmethanol
IUPAC name
cyclohexylmethanol
Molecular weight
114.185
clogP
1.844
clogS
-1.089
Frequency
0.0021
HBond Acceptor
1
HBond Donor
1
Total PolarSurface Area
20.23
Number of Rings
1
Rotatable Bond
1
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00107 | Oxyphenonium |
|
Muscarinic Antagonists; Parasympatholytics; Mydriatics; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Synthetic Anticholinergics, Quaternary Ammonium Compounds; | For the treatment of visceral spasms. |
| FDBD00258 | Trihexyphenidyl |
|
Antiparkinson Agents; Muscarinic Antagonists; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Anticholinergics; Tertiary Amines; | Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs. |
| FDBD00264 | Oxyphencyclimine |
|
Cholinergic Antagonists; Antispasmodics; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Synthetic Anticholinergics, Esters With Tertiary Amino Group; | For the treatment of peptic ulcer disease and the relief of smooth muscle spasms in gastrointestinal disorders. |
| FDBD00267 | Procyclidine |
|
Antiparkinson Agents; Muscarinic Antagonists; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Anticholinergics; Tertiary Amines; | For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents. |
| FDBD00913 | Oxybutynin |
|
Muscarinic Antagonists; Parasympatholytics; Cholinergic Antagonists; Antispasmodics; Muscle Relaxants, Genitourinary; Genito Urinary System and Sex Hormones; Drugs for Urinary Frequency and Incontinence; Urological Agents; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of overactive bladder. |
| FDBD01483 | Hexocyclium |
|
Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Synthetic Anticholinergics, Quaternary Ammonium Compounds; |
6 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 2zmj_ligand_3_17.mol2 | 2zmj | 1 | -8.31 | C1[C@H]2C[C@H]3C[C@@]1(C[C@H](C3)C2)C[C@@H](C)O | 14 |
| 2zmj_ligand_2_13.mol2 | 2zmj | 1 | -7.94 | C1[C@H]2C[C@H]3C[C@@]1(C[C@H](C3)C2)CCO | 13 |
| 4mm7_ligand_2_0.mol2 | 4mm7 | 1 | -7.38 | C(C1(CCCCC1)O)C | 9 |
| 1fq4_ligand_4_1490.mol2 | 1fq4 | 1 | -7.24 | [C@@H](O)(C)CCC1CCCCC1 | 11 |
| 1fq7_ligand_4_2990.mol2 | 1fq7 | 1 | -7.23 | C(C[C@@H](O)C)C1CCCCC1 | 11 |
| 4mm7_ligand_1_0.mol2 | 4mm7 | 1 | -7.18 | CC1(CCCCC1)O | 8 |
| 5all_ligand_1_1.mol2 | 5all | 1 | -7.09 | C(O)[C@@H]1C[C@@H](CCC1)C | 9 |
174 ,
18
